chartexchange

MLNT
Melinta Therapeutics Inc
stockOTC

InactiveJan 10, 2020 4:00:00 PM EST
0.50USD-5.696%(-0.03)
Loading…
Loading…
Sector
Healthcare
Industry
Biotechnology
HQ
CT, USA
MLNT Profile

Melinta Therapeutics Inc is a commercial-stage biopharmaceutical company. It is developing antibiotic, Baxdela (delafloxacin), for the treatment of adults with serious skin infections known as acute bacterial skin and skin structure infections.

MLNT Performance
PeriodPriceDateChange